Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q76KB1

Entry ID Method Resolution Chain Position Source
3F5F X-ray 265 A A 69-356 PDB
4NDZ X-ray 345 A A/B/C/D/E/F 69-356 PDB
AF-Q76KB1-F1 Predicted AlphaFoldDB

7 variants for Q76KB1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1057724270 32 Q>H No Ensembl
rs1060457858 33 K>M No Ensembl
rs1059149497 33 K>N No Ensembl
rs739494205 147 D>A No Ensembl
rs736873524 171 V>G No Ensembl
rs735865524 175 Y>F No Ensembl
rs734291166 207 S>A No Ensembl

No associated diseases with Q76KB1

No regional properties for Q76KB1

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q76KB1

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus membrane ; Single-pass type II membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

3 GO annotations of molecular function

Name Definition
heparan sulfate 2-O-sulfotransferase activity Catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate + heparan sulfate = adenosine 3',5'-bisphosphate + heparan sulfate 2-O-sulfate; results in 2-O-sulfation of iduronic acid residues in heparan sulfate.
identical protein binding Binding to an identical protein or proteins.
sulfotransferase activity Catalysis of the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the hydroxyl group of an acceptor, producing the sulfated derivative and 3'-phosphoadenosine 5'-phosphate.

5 GO annotations of biological process

Name Definition
gene expression The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes.
heparan sulfate proteoglycan biosynthetic process, enzymatic modification The modification, often by sulfation, of sugars incorporated into heparan sulfate after polymerization.
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process The chemical reactions and pathways resulting in the formation of polysaccharide chain component of heparan sulfate proteoglycan.
heparin metabolic process The chemical reactions and pathways involving heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells. They are similar to heparan sulfates but are of somewhat higher average Mr (6000-20000) and contain fewer N-acetyl groups and more N-sulfate and O-sulfate groups; they may be attached in the same manner to protein, forming proteoglycans. They consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
ureteric bud formation The developmental process pertaining to the initial formation of the ureteric bud from the Wolffian duct. This process begins when the bud protrudes from the duct and ends when it is a recognizable bud.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q7LGA3 HS2ST1 Heparan sulfate 2-O-sulfotransferase 1 Homo sapiens (Human) PR
Q8R3H7 Hs2st1 Heparan sulfate 2-O-sulfotransferase 1 Mus musculus (Mouse) PR
10 20 30 40 50 60
MGLLRIMLPP KLQLLAVLVF GVAVLFLENQ IQKLEESRGK LERAIARHEV REIEQRHTAD
70 80 90 100 110 120
GPRQEVALDE EDDVVIIYNR VPKTASTSFT NIAYDLCAKN RYHVLHINTT KNNPVMSLQD
130 140 150 160 170 180
QVRFVKNVTS WKEMKPGFYH GHVSYLDFAK FGVKKKPIYI NVIRDPIERL VSYYYFLRFG
190 200 210 220 230 240
DDYRPGLRRR KQGDKKTFDE CVAAGGSDCA PEKLWLQIPF FCGHSSECWN VGSRWALEQA
250 260 270 280 290 300
KYNLINEYFL VGVTEELEDF IMLLEAALPR FFRGATELYR TGKKSHLRKT TEKKLPTKET
310 320 330 340 350
IAKLQQSEIW KMENEFYEFA LEQFQFVRAH AVREKDGELY ILAQNFFYEK IYPKSN